Provided by Tiger Trade Technology Pte. Ltd.

Tango Therapeutics Inc.

12.20
-0.1500-1.21%
Post-market: 12.450.2499+2.05%18:47 EST
Volume:1.65M
Turnover:20.27M
Market Cap:1.64B
PE:-13.38
High:12.75
Open:12.23
Low:12.03
Close:12.35
52wk High:13.48
52wk Low:1.03
Shares:134.68M
Float Shares:55.14M
Volume Ratio:0.63
T/O Rate:2.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9117
EPS(LYR):-1.1929
ROE:-51.65%
ROA:-24.52%
PB:10.27
PE(LYR):-10.23

Loading ...

Tango Therapeutics Inc. Publishes Update to Financial Calendar

Reuters
·
Feb 18

Guggenheim Keeps Their Buy Rating on Tango Therapeutics (TNGX)

TIPRANKS
·
Feb 06

Tango Therapeutics CFO Daniella Beckman Reports Disposal of Common Shares

Reuters
·
Feb 05

Tango Therapeutics CEO to Join Guggenheim Emerging Outlook Biotech Summit

Reuters
·
Feb 03

A Look At Tango Therapeutics (TNGX) Valuation After CEO Transition And Strong Recent Share Price Returns

Simply Wall St.
·
Jan 22

Tango Therapeutics, Inc.'s (NASDAQ:TNGX) 53% Price Boost Is Out Of Tune With Revenues

Simply Wall St.
·
Jan 19

Is Tango Therapeutics’ New CEO (TNGX) Quietly Redefining Its Clinical Strategy And Execution Priorities?

Simply Wall St.
·
Jan 18

Tango Therapeutics (TNGX) Valuation Check After Leadership Reshuffle And Strong Recent Share Price Performance

Simply Wall St.
·
Jan 15

Tango Therapeutics Unveils Pipeline Advancements Targeting MTAP-Deleted Cancers

Reuters
·
Jan 14

Tango Therapeutics announces retirement of CEO Weber, Peters to succeed

TIPRANKS
·
Jan 08

Tango Therapeutics Names Malte Peters CEO as Barbara Weber Retires

Reuters
·
Jan 08

Tango Therapeutics Inc - Malte Peters Appointed President and CEO of Tango Therapeutics

THOMSON REUTERS
·
Jan 08

Tango Therapeutics Inc - Barbara Weber to Become Executive Chair in 2026

THOMSON REUTERS
·
Jan 08

Tango Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Director Sung Lee

Reuters
·
Jan 07

Press Release: Tango Therapeutics Appoints Sung Lee to Board of Directors

Dow Jones
·
Jan 05

Tango Therapeutics CEO to Present at J.P. Morgan Healthcare Conference

Reuters
·
Dec 17, 2025

Tango Therapeutics (TNGX): Assessing Valuation Following New Equity Offering and Shelf Registration Moves

Simply Wall St.
·
Nov 22, 2025

13D Filings -- Barrons.com

Dow Jones
·
Nov 22, 2025

BRIEF-Tango Therapeutics Files Prospectus For Resale Of 1.7 Million Shares By Selling Stockholder - SEC Filing

Reuters
·
Nov 21, 2025

Tango Therapeutics files to sell 1.73M shares of common stock for holders

TIPRANKS
·
Nov 21, 2025